Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.

Ito Y, Miyauchi A, Kudo T, Higashiyama T, Masuoka H, Kihara M, Miya A.

Thyroid. 2019 Oct 25. doi: 10.1089/thy.2019.0396. [Epub ahead of print]

PMID:
31650907
2.

Prognostic Value of Extranodal Tumor Extension in Papillary Thyroid Carcinoma: Proposal for Upstaging of Cases with Extranodal Tumor Extension.

Ito Y, Miyauchi A, Masuoka H, Higashiyama T, Kihara M, Miya A.

World J Surg. 2019 Oct 11. doi: 10.1007/s00268-019-05232-3. [Epub ahead of print]

PMID:
31605175
3.

Subclassification of Tumor Extension and Nodal Metastasis in Papillary Thyroid Cancer to Improve Prognostic Accuracy of the Eighth Edition of the Tumor-Node-Metastasis Classification.

Ito Y, Miyauchi A, Kihara M, Masuoka H, Higashiyama T, Miya A.

World J Surg. 2019 Aug 19. doi: 10.1007/s00268-019-05120-w. [Epub ahead of print]

PMID:
31428837
4.

Gitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report.

Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T.

Medicine (Baltimore). 2019 Jul;98(28):e16408. doi: 10.1097/MD.0000000000016408.

5.

Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.

Ito M, Miyauchi A, Hisakado M, Yoshioka W, Kudo T, Nishihara E, Kihara M, Ito Y, Miya A, Fukata S, Nishikawa M, Nakamura H.

Endocr J. 2019 Jul 2. doi: 10.1507/endocrj.EJ19-0094. [Epub ahead of print]

6.

Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer.

Suzuki C, Kiyota N, Imamura Y, Goto H, Suto H, Chayahara N, Toyoda M, Ito Y, Miya A, Miyauchi A, Otsuki N, Nibu KI, Minami H.

Head Neck. 2019 Sep;41(9):3023-3032. doi: 10.1002/hed.25784. Epub 2019 Apr 23.

PMID:
31013380
7.

Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.

Ito Y, Miyauchi A, Oda H, Masuoka H, Higashiyama T, Kihara M, Miya A.

Endocr J. 2019 Feb 28;66(2):127-134. doi: 10.1507/endocrj.EJ17-0061. Epub 2019 Jan 9.

8.

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma.

Hyogo Y, Kiyota N, Otsuki N, Goto S, Imamura Y, Chayahara N, Toyoda M, Nibu KI, Hyodo T, Hara S, Masuoka H, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H.

Case Rep Oncol. 2018 Nov 12;11(3):735-741. doi: 10.1159/000494080. eCollection 2018 Sep-Dec.

9.

Calcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors.

Kihara M, Hirokawa M, Kudo T, Hayashi T, Yamamoto M, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Miya A, Miyauchi A.

Thyroid Res. 2018 Oct 30;11:15. doi: 10.1186/s13044-018-0059-4. eCollection 2018.

10.

Innervation of the tibial epiphysis through the intercondylar foramen.

Matsuo K, Ji S, Miya A, Yoda M, Hamada Y, Tanaka T, Takao-Kawabata R, Kawaai K, Kuroda Y, Shibata S.

Bone. 2019 Mar;120:297-304. doi: 10.1016/j.bone.2018.11.007. Epub 2018 Nov 13.

11.

Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.

Miyauchi A, Kudo T, Ito Y, Oda H, Yamamoto M, Sasai H, Higashiyama T, Masuoka H, Fukushima M, Kihara M, Miya A.

Surgery. 2019 Jan;165(1):25-30. doi: 10.1016/j.surg.2018.07.045. Epub 2018 Nov 6.

12.

Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.

Cho KY, Nakamura A, Omori K, Takase T, Miya A, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Diabetes Obes Metab. 2019 Mar;21(3):710-714. doi: 10.1111/dom.13557. Epub 2018 Nov 8.

13.

Calcifications in Thyroid Tumors on Ultrasonography: Calcification Types and Relationship with Histopathological Type.

Kobayashi K, Fujimoto T, Ota H, Hirokawa M, Yabuta T, Masuoka H, Fukushima M, Higashiyama T, Kihara M, Ito Y, Miya A, Miyauchi A.

Ultrasound Int Open. 2018 Apr;4(2):E45-E51. doi: 10.1055/a-0591-6070. Epub 2018 Jul 5.

14.

Spontaneous Deceleration and Acceleration of Growth Rate in Medullary Thyroid Carcinomas Suggested by Changes in Calcitonin Doubling Times Over Long-Term Surveillance.

Miyauchi A, Kudo T, Kihara M, Oda H, Ito Y, Miya A.

World J Surg. 2019 Feb;43(2):504-512. doi: 10.1007/s00268-018-4789-1.

15.

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.

Takahashi K, Cho KY, Nakamura A, Miya A, Miyoshi A, Yamamoto C, Nomoto H, Niwa H, Takahashi K, Manda N, Kurihara Y, Aoki S, Ito YM, Atsumi T, Miyoshi H.

J Diabetes Investig. 2019 Mar;10(2):429-438. doi: 10.1111/jdi.12913. Epub 2018 Sep 26.

16.

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.

Takase T, Nakamura A, Yamamoto C, Nomoto H, Miya A, Dannoura M, Cho KY, Kurihara Y, Manda N, Aoki S, Atsumi T, Miyoshi H.

J Diabetes Investig. 2019 May;10(3):699-705. doi: 10.1111/jdi.12906. Epub 2018 Sep 19.

17.

Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.

Ito Y, Miyauchi A, Kihara M, Higashiiyama T, Fukushima M, Miya A.

World J Surg. 2018 Dec;42(12):3954-3966. doi: 10.1007/s00268-018-4738-z.

18.

Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time.

Kasahara T, Miyauchi A, Kudo T, Nishihara E, Ito M, Ito Y, Kihara M, Miya A.

J Thyroid Res. 2018 May 16;2018:6470251. doi: 10.1155/2018/6470251. eCollection 2018.

19.

Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.

Goto H, Kiyota N, Otsuki N, Imamura Y, Chayahara N, Suto H, Nagatani Y, Toyoda M, Mukohara T, Nibu KI, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H.

Auris Nasus Larynx. 2018 Dec;45(6):1249-1252. doi: 10.1016/j.anl.2018.05.003. Epub 2018 May 18.

PMID:
29779695
20.

Prognostic value of the 8th edition of the tumor-node-metastasis classification for patients with papillary thyroid carcinoma: a single-institution study at a high-volume center in Japan.

Ito Y, Miyauchi A, Hirokawa M, Yamamoto M, Oda H, Masuoka H, Sasai H, Fukushima M, Higashiyama T, Kihara M, Miya A.

Endocr J. 2018 Jul 28;65(7):707-716. doi: 10.1507/endocrj.EJ18-0019. Epub 2018 Apr 20.

21.

Prognostic value of the 8th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan.

Ito Y, Miyauchi A, Hirokawa M, Yamamoto M, Oda H, Masuoka H, Sasai H, Fukushima M, Higashiyama T, Kihara M, Miya A.

Endocr J. 2018 Jun 27;65(6):621-627. doi: 10.1507/endocrj.EJ17-0524. Epub 2018 Apr 4.

22.

Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes.

Miya A, Nakamura A, Miyoshi H, Takano Y, Sunagoya K, Hayasaka K, Shimizu C, Terauchi Y, Atsumi T.

Front Endocrinol (Lausanne). 2018 Mar 20;9:81. doi: 10.3389/fendo.2018.00081. eCollection 2018.

23.

Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option.

Ito Y, Miyauchi A, Kudo T, Oda H, Yamamoto M, Sasai H, Masuoka H, Fukushima M, Higashiyama T, Kihara M, Miya A.

Thyroid. 2018 Apr;28(4):488-495. doi: 10.1089/thy.2017.0448. Epub 2018 Apr 2.

24.

Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia distinct from the salivary type.

Hirokawa M, Takada N, Abe H, Suzuki A, Higuchi M, Miya A, Hayashi T, Fukushima M, Kawahara A, Miyauchi A.

Endocr J. 2018 Apr 26;65(4):427-436. doi: 10.1507/endocrj.EJ17-0462. Epub 2018 Feb 8.

25.

Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.

Ito Y, Miyauchi A, Masuoka H, Fukushima M, Kihara M, Miya A.

World J Surg. 2018 Aug;42(8):2462-2468. doi: 10.1007/s00268-018-4497-x.

26.

Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.

Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A.

World J Surg. 2018 Mar;42(3):615-622. doi: 10.1007/s00268-018-4479-z.

27.

Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance.

Miyauchi A, Kudo T, Ito Y, Oda H, Sasai H, Higashiyama T, Fukushima M, Masuoka H, Kihara M, Miya A.

Surgery. 2018 Jan;163(1):48-52. doi: 10.1016/j.surg.2017.03.028. Epub 2017 Nov 2.

28.

The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).

Kitao N, Miyoshi H, Furumoto T, Ono K, Nomoto H, Miya A, Yamamoto C, Inoue A, Tsuchida K, Manda N, Kurihara Y, Aoki S, Nakamura A, Atsumi T; SAIS Study Group.

Cardiovasc Diabetol. 2017 Oct 10;16(1):125. doi: 10.1186/s12933-017-0607-6.

29.

Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma.

Kihara M, Miyauchi A, Kudo T, Hirokawa M, Miya A.

Surg Today. 2018 Feb;48(2):223-228. doi: 10.1007/s00595-017-1578-7. Epub 2017 Aug 18.

PMID:
28821980
30.

"Nodule in Nodule" on Thyroid Ultrasonography: Possibility of Follicular Carcinoma Transformed from Benign Thyroid Tumor.

Kobayashi K, Ota H, Hirokawa M, Yabuta T, Fukushima M, Masuoka H, Higashiyama T, Kihara M, Ito Y, Miya A, Miyauchi A.

Eur Thyroid J. 2017 Apr;6(2):101-107. doi: 10.1159/000452971. Epub 2016 Dec 13.

31.

The Effectiveness of Prophylactic Modified Neck Dissection for Reducing the Development of Lymph Node Recurrence of Papillary Thyroid Carcinoma.

Ito Y, Miyauchi A, Kudo T, Kihara M, Fukushima M, Miya A.

World J Surg. 2017 Sep;41(9):2283-2289. doi: 10.1007/s00268-017-4023-6.

32.

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial.

Miya A, Nakamura A, Miyoshi H, Cho KY, Nagai S, Kurihara Y, Aoki S, Taguri M, Terauchi Y, Atsumi T.

J Diabetes Investig. 2018 Jan;9(1):119-126. doi: 10.1111/jdi.12654. Epub 2017 Jul 10.

33.

Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.

Ito M, Miyauchi A, Hisakado M, Yoshioka W, Ide A, Kudo T, Nishihara E, Kihara M, Ito Y, Kobayashi K, Miya A, Fukata S, Nishikawa M, Nakamura H, Amino N.

Thyroid. 2017 Apr;27(4):484-490. doi: 10.1089/thy.2016.0426. Epub 2017 Feb 6.

34.

Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.

Ito Y, Hirokawa M, Miyauchi A, Higashiyama T, Kihara M, Miya A.

World J Surg. 2017 Mar;41(3):742-747. doi: 10.1007/s00268-016-3784-7.

PMID:
27807709
35.

Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.

Ito Y, Hirokawa M, Miyauchi A, Masuoka H, Yabuta T, Fukushima M, Kihara M, Higashiyama T, Kobayashi K, Miya A.

Endocr J. 2016 Oct 29;63(10):913-917. Epub 2016 Jul 16.

36.

Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.

Tane K, Egawa C, Takao S, Yamagami K, Miyashita M, Baba M, Ichii S, Konishi M, Kikawa Y, Minohata J, Okuno T, Miyauchi K, Wakita K, Suwa H, Hashimoto T, Nishino M, Matsumoto T, Hidaka T, Konishi Y, Sakoda Y, Miya A, Kishimoto M, Nishikawa H, Kono S, Kokufu I, Sakita I, Kitatsuji K, Oh K, Akazawa K, Miyoshi Y.

Breast Cancer. 2017 Jul;24(4):528-534. doi: 10.1007/s12282-016-0735-y. Epub 2016 Oct 12.

PMID:
27730528
37.

Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.

Oda H, Miyauchi A, Ito Y, Sasai H, Masuoka H, Yabuta T, Fukushima M, Higashiyama T, Kihara M, Kobayashi K, Miya A.

Endocr J. 2017 Jan 30;64(1):59-64. doi: 10.1507/endocrj.EJ16-0381. Epub 2016 Sep 22.

38.

Diagnosis and surgical indications of oxyphilic follicular tumors in Japan: Surgical specimens and cytology.

Ito Y, Hirokawa M, Miyauchi A, Kihara M, Yabuta T, Masuoka H, Fukushima M, Higashiyama T, Kobayashi K, Miya A.

Endocr J. 2016 Nov 30;63(11):977-982. Epub 2016 Jul 26.

39.

Surgical Methods and Experiences of Surgeons did not Significantly Affect the Recovery in Phonation Following Reconstruction of the Recurrent Laryngeal Nerve.

Yoshioka K, Miyauchi A, Fukushima M, Kobayashi K, Kihara M, Miya A.

World J Surg. 2016 Dec;40(12):2948-2955. doi: 10.1007/s00268-016-3634-7.

40.

Right-sided aortic arch and aberrant left subclavian artery with or without a left nonrecurrent inferior laryngeal nerve.

Masuoka H, Miyauchi A, Higashiyama T, Yabuta T, Kihara M, Miya A.

Head Neck. 2016 Oct;38(10):E2508-11. doi: 10.1002/hed.24492. Epub 2016 Apr 30.

41.
42.

Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.

Ito Y, Miyauchi A, Kihara M, Kudo T, Miya A.

Endocr J. 2016 Jul 30;63(7):663-7. doi: 10.1507/endocrj.EJ16-0140. Epub 2016 Apr 19.

43.

Tumor protrusion with intensive blood signals on ultrasonography is a strongly suggestive finding of follicular thyroid carcinoma.

Kobayashi K, Hirokawa M, Yabuta T, Masuoka H, Fukushima M, Kihara M, Higashiyama T, Ito Y, Miya A, Amino N, Miyauchi A.

Med Ultrason. 2016 Mar;18(1):25-9. doi: 10.11152/mu.2013.2066.181.kok.

44.

Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.

Kihara M, Miyauchi A, Yoshioka K, Oda H, Nakayama A, Sasai H, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Kobayashi K, Miya A.

Auris Nasus Larynx. 2016 Oct;43(5):551-5. doi: 10.1016/j.anl.2015.12.016. Epub 2016 Feb 1.

PMID:
26837867
45.

Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.

Ito Y, Miyauchi A, Kudo T, Ota H, Yoshioka K, Oda H, Sasai H, Nakayama A, Yabuta T, Masuoka H, Fukushima M, Higashiyama T, Kihara M, Kobayashi K, Miya A.

Thyroid. 2016 Jan;26(1):156-60. doi: 10.1089/thy.2015.0393. Epub 2015 Dec 15.

46.

Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease.

Yoshioka W, Miyauchi A, Ito M, Kudo T, Tamai H, Nishihara E, Kihara M, Miya A, Amino N.

Endocr J. 2016;63(2):179-85. doi: 10.1507/endocrj.EJ15-0492. Epub 2015 Dec 3.

47.

Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.

Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, Masuoka H, Yabuta T, Fukushima M, Higashiyama T, Kihara M, Kobayashi K, Miya A.

Thyroid. 2016 Jan;26(1):150-5. doi: 10.1089/thy.2015.0313. Epub 2015 Nov 5.

48.

Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.

Egawa C, Hirokaga K, Takao S, Yamagami K, Miyashita M, Baba M, Ichii S, Konishi M, Kikawa Y, Minohata J, Okuno T, Miyauchi K, Wakita K, Suwa H, Hashimoto T, Nishino M, Matsumoto T, Hidaka T, Konishi Y, Sakoda Y, Miya A, Mitsunobu M, Nishikawa H, Kono S, Kokufu I, Sakita I, Kitatsuji K, Oh K, Miyoshi Y.

Int J Clin Oncol. 2016 Apr;21(2):262-269. doi: 10.1007/s10147-015-0905-5. Epub 2015 Sep 28.

PMID:
26411314
49.

Revisiting Low-Risk Thyroid Papillary Microcarcinomas Resected Without Observation: Was Immediate Surgery Necessary?

Ito Y, Miyauchi A, Oda H, Kobayashi K, Kihara M, Miya A.

World J Surg. 2016 Mar;40(3):523-8. doi: 10.1007/s00268-015-3184-4.

PMID:
26243564
50.

Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.

Ito M, Miyauchi A, Kang S, Hisakado M, Yoshioka W, Ide A, Kudo T, Nishihara E, Kihara M, Ito Y, Kobayashi K, Miya A, Fukata S, Nakamura H, Amino N.

Eur J Endocrinol. 2015 Sep;173(3):333-40. doi: 10.1530/EJE-15-0138. Epub 2015 Jun 15.

PMID:
26077156

Supplemental Content

Support Center